A double-blind, randomized, parallel group, placebo-controlled sleep laboratory efficacy and safety study with Org 50081 [esmirtazapine] in elderly subjects with chronic primary insomnia.
Phase of Trial: Phase III
Latest Information Update: 08 Jan 2017
At a glance
- Drugs Esmirtazapine (Primary)
- Indications Insomnia
- Focus Therapeutic Use
- Acronyms Turquoise
- Sponsors Merck & Co; Schering-Plough
- 29 Jan 2010 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 25 Dec 2009 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
- 22 Jul 2009 Additional trial locations identified as reported by ClinicalTrials.gov.